Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yasushige Akada is active.

Publication


Featured researches published by Yasushige Akada.


Journal of Cardiovascular Pharmacology | 1993

Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate on the physical properties of arterial walls in high cholesterol diet-fed rabbits

Masami Sato; Yukio Katsuki; Hideo Kanehiro; Midori Iimura; Yasushige Akada; Masahiro Mizota; Yasuyuki Kunihiro

The effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate (EPA-E) on in vivo physical properties of arteriosclerotic aorta and femoral artery in high cholesterol diet (HCD)-fed rabbits were studied. The aortic pulse wave velocity (PWV) of rabbits fed HCD for 12 weeks (control group) tended to be higher than that of rabbits fed a normal diet (normal group). Because the PWVs in HCD-fed rabbits administered orally with 30 and 300 mg/kg/day EPA-E were significantly lower than the PWV of the control group, the distensibility of arteriosclerotic aorta was improved with administration of EPA-E. The stiffness parameter (β) value as an in vivo indicator of arteriosclerosis was significantly higher in the control group than in the normal group and improved with administration of EPA-E to almost the same level as that of the normal group. The β-values were in significant negative correlation with medial elastin content and medial smooth muscle cell (SMC) density in thoracic aorta and in positive correlation with the free cholesterol content in abdominal aortic SMC. On the other hand, they were not correlated with either the cross-sectional area of intimal thickening lesions or the plasma lipid levels measured simultaneously. The femoral PWVs were, like those in the aorta, higher in the control group as compared with the normal group, and the changes were improved with administration of EPA-E. These results show that EPA-E improved the in vivo distensibility of arteriosclerotic arteries in HCD-fed rabbits. The mechanism of this improvement with EPA-E appeared to be related to histologic amelioration in the aortic medial elastic fibers and SMC and to protection from free cholesterol accumulation in SMC as one of the probable causes.


European Journal of Pharmacology | 2006

Potent analgesic effects of a putative sodium channel blocker M58373 on formalin-induced and neuropathic pain in rats

Yasushige Akada; Shinichi Ogawa; Ken-ichi Amano; Yuka Fukudome; Fumiaki Yamasaki; Manabu Itoh; Ichiro Yamamoto


Archive | 1997

Nerve cell protective agents

Ichiro Yamamoto; Manabu Itoh; Masato Shimojo; Yasunobu Yumiya; Takafumi Mukaihira; Yasushige Akada


Archive | 2001

Agents for treating neuropathic pain

Ichiro Yamamoto; Manabu Itoh; Fumiaki Yamasaki; Yasushige Akada; Yutaka Miyazaki; Shinichi Ogawa


Archive | 2003

Agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient

Yasushige Akada; Kazuyuki Matsuura


European Journal of Pharmacology | 2005

Analgesic properties of the novel compound M43068 in rat models of acute and neuropathic pain

Yasushige Akada; Reiko Mori; Yutaka Kato; Fumiaki Yamasaki; Hidenori Mochizuki


Archive | 2000

Remedies for neuropathic pain

Ichiro Yamamoto; Manabu Itoh; Fumiaki Yamasaki; Yasushige Akada; Yutaka Miyazaki; Shinichi Ogawa


Japanese Journal of Pharmacology | 1997

Effects of a Calcium Antagonist, Lacidipine, on Experimental Focal Cerebral Ischemia in Rats

Hideyuki Funato; Hiroyuki Kawano; Yasushige Akada; Yukio Katsuki; Masami Sato; Akio Uemura


Archive | 2006

Heterocyclidene acetamide derivative

Hideharu Uchida; Naoto Kosuga; Tsutomu Satoh; Daido Hotta; Tomoyuki Kamino; Yoshitaka Maeda; Ken-ichi Amano; Yasushige Akada


Archive | 2002

4-hydroxpiperidine derivative with analgetic activity

Ichiro Yamamoto; Kazuyuki Matsuura; Kazuhiro Suzuki; Kazuo Kato; Yasushige Akada; Hidenori Mochizuki; Akihito Shimoi

Collaboration


Dive into the Yasushige Akada's collaboration.

Top Co-Authors

Avatar

Ichiro Yamamoto

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Fumiaki Yamasaki

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Manabu Itoh

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kazuyuki Matsuura

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Shinichi Ogawa

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Yutaka Miyazaki

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kazuhiro Suzuki

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kazuo Kato

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Akihito Shimoi

Mochida Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge